nodes	percent_of_prediction	percent_of_DWPC	metapath
Teniposide—Topoisomerase Inhibitors—Topotecan—cervical cancer	0.809	1	CiPCiCtD
Teniposide—ABCG2—Topotecan—cervical cancer	0.0953	0.822	CbGbCtD
Teniposide—CYP3A4—Topotecan—cervical cancer	0.0206	0.178	CbGbCtD
Teniposide—Acute leukaemia—Topotecan—cervical cancer	0.00314	0.154	CcSEcCtD
Teniposide—NCOA3—Irinotecan—Topotecan—cervical cancer	0.00207	0.879	CbGdCrCtD
Teniposide—Myelosuppression—Topotecan—cervical cancer	0.00191	0.0937	CcSEcCtD
Teniposide—NCOA1—uterine cervix—cervical cancer	0.00165	0.0568	CbGeAlD
Teniposide—Mucosal inflammation—Topotecan—cervical cancer	0.00162	0.0794	CcSEcCtD
Teniposide—NCOA1—decidua—cervical cancer	0.00157	0.0541	CbGeAlD
Teniposide—NCOA1—endometrium—cervical cancer	0.00149	0.0514	CbGeAlD
Teniposide—NCOA3—Validated nuclear estrogen receptor alpha network—POU4F1—cervical cancer	0.00146	0.0634	CbGpPWpGaD
Teniposide—NCOA1—mammalian vulva—cervical cancer	0.00144	0.0497	CbGeAlD
Teniposide—NCOA3—Retinoic acid receptors-mediated signaling—RARB—cervical cancer	0.0014	0.061	CbGpPWpGaD
Teniposide—NCOA1—uterus—cervical cancer	0.00137	0.0473	CbGeAlD
Teniposide—NCOA1—RXR and RAR heterodimerization with other nuclear receptor—RARB—cervical cancer	0.0013	0.0566	CbGpPWpGaD
Teniposide—NCOA1—Notch-mediated HES/HEY network—YY1—cervical cancer	0.00129	0.0562	CbGpPWpGaD
Teniposide—NCOA1—Validated nuclear estrogen receptor alpha network—POU4F1—cervical cancer	0.0012	0.0524	CbGpPWpGaD
Teniposide—NCOA1—Retinoic acid receptors-mediated signaling—RARB—cervical cancer	0.00116	0.0505	CbGpPWpGaD
Teniposide—NCOA3—uterine cervix—cervical cancer	0.00115	0.0396	CbGeAlD
Teniposide—NCOA1—female gonad—cervical cancer	0.00112	0.0387	CbGeAlD
Teniposide—NCOA3—Androgen receptor signaling pathway—PIAS3—cervical cancer	0.00112	0.0487	CbGpPWpGaD
Teniposide—NCOA1—vagina—cervical cancer	0.00112	0.0385	CbGeAlD
Teniposide—NCOA3—decidua—cervical cancer	0.00109	0.0377	CbGeAlD
Teniposide—NCOA3—renal system—cervical cancer	0.00107	0.037	CbGeAlD
Teniposide—NCOA3—endometrium—cervical cancer	0.00104	0.0358	CbGeAlD
Teniposide—Extravasation—Topotecan—cervical cancer	0.00103	0.0504	CcSEcCtD
Teniposide—NCOA3—mammalian vulva—cervical cancer	0.001	0.0346	CbGeAlD
Teniposide—NCOA1—Regulation of nuclear SMAD2/3 signaling—PIAS3—cervical cancer	0.000998	0.0434	CbGpPWpGaD
Teniposide—NCOA3—uterus—cervical cancer	0.000956	0.033	CbGeAlD
Teniposide—ABCC6—renal system—cervical cancer	0.000944	0.0326	CbGeAlD
Teniposide—NCOA1—Androgen receptor signaling pathway—PIAS3—cervical cancer	0.000925	0.0403	CbGpPWpGaD
Teniposide—NCOA3—female reproductive system—cervical cancer	0.00086	0.0297	CbGeAlD
Teniposide—Neuropathy—Topotecan—cervical cancer	0.000842	0.0413	CcSEcCtD
Teniposide—Neoplasm—Topotecan—cervical cancer	0.000811	0.0397	CcSEcCtD
Teniposide—NCOA3—female gonad—cervical cancer	0.000782	0.027	CbGeAlD
Teniposide—Sepsis—Topotecan—cervical cancer	0.000778	0.0381	CcSEcCtD
Teniposide—NCOA3—vagina—cervical cancer	0.000778	0.0268	CbGeAlD
Teniposide—NCOA1—HIF-1-alpha transcription factor network—CA9—cervical cancer	0.000726	0.0316	CbGpPWpGaD
Teniposide—NCOA1—lymph node—cervical cancer	0.000722	0.0249	CbGeAlD
Teniposide—NCOA3—Androgen receptor signaling pathway—UBE3A—cervical cancer	0.000721	0.0314	CbGpPWpGaD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—PIAS3—cervical cancer	0.000693	0.0301	CbGpPWpGaD
Teniposide—TOP2A—uterine cervix—cervical cancer	0.000673	0.0232	CbGeAlD
Teniposide—TOP2A—decidua—cervical cancer	0.000641	0.0221	CbGeAlD
Teniposide—TOP2A—endometrium—cervical cancer	0.000609	0.021	CbGeAlD
Teniposide—NCOA1—Androgen receptor signaling pathway—UBE3A—cervical cancer	0.000596	0.0259	CbGpPWpGaD
Teniposide—TOP2A—mammalian vulva—cervical cancer	0.000589	0.0203	CbGeAlD
Teniposide—TOP2A—uterus—cervical cancer	0.000561	0.0194	CbGeAlD
Teniposide—Pancytopenia—Topotecan—cervical cancer	0.000534	0.0262	CcSEcCtD
Teniposide—Neutropenia—Topotecan—cervical cancer	0.000526	0.0258	CcSEcCtD
Teniposide—NCOA3—lymph node—cervical cancer	0.000503	0.0173	CbGeAlD
Teniposide—Neuropathy peripheral—Topotecan—cervical cancer	0.000492	0.0241	CcSEcCtD
Teniposide—Stomatitis—Topotecan—cervical cancer	0.000489	0.024	CcSEcCtD
Teniposide—Sweating—Topotecan—cervical cancer	0.000481	0.0236	CcSEcCtD
Teniposide—TOP2A—female gonad—cervical cancer	0.000459	0.0158	CbGeAlD
Teniposide—TOP2A—vagina—cervical cancer	0.000456	0.0157	CbGeAlD
Teniposide—Haemoglobin—Topotecan—cervical cancer	0.000453	0.0222	CcSEcCtD
Teniposide—Haemorrhage—Topotecan—cervical cancer	0.00045	0.0221	CcSEcCtD
Teniposide—NCOA1—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.000448	0.0195	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—INSM1—cervical cancer	0.000441	0.0192	CbGpPWpGaD
Teniposide—NCOA1—Notch-mediated HES/HEY network—HES1—cervical cancer	0.00044	0.0191	CbGpPWpGaD
Teniposide—Chills—Topotecan—cervical cancer	0.000404	0.0198	CcSEcCtD
Teniposide—Alopecia—Topotecan—cervical cancer	0.000398	0.0195	CcSEcCtD
Teniposide—NCOA1—Developmental Biology—INSM1—cervical cancer	0.000364	0.0159	CbGpPWpGaD
Teniposide—Anaemia—Topotecan—cervical cancer	0.000362	0.0178	CcSEcCtD
Teniposide—Leukopenia—Topotecan—cervical cancer	0.000351	0.0172	CcSEcCtD
Teniposide—ABCG2—uterine cervix—cervical cancer	0.000336	0.0116	CbGeAlD
Teniposide—Chest pain—Topotecan—cervical cancer	0.000334	0.0164	CcSEcCtD
Teniposide—NCOA1—Notch-mediated HES/HEY network—NOTCH1—cervical cancer	0.000332	0.0145	CbGpPWpGaD
Teniposide—ABCG2—decidua—cervical cancer	0.00032	0.011	CbGeAlD
Teniposide—Infection—Topotecan—cervical cancer	0.000318	0.0156	CcSEcCtD
Teniposide—Thrombocytopenia—Topotecan—cervical cancer	0.000313	0.0154	CcSEcCtD
Teniposide—CYP3A5—uterine cervix—cervical cancer	0.000312	0.0107	CbGeAlD
Teniposide—Hyperhidrosis—Topotecan—cervical cancer	0.000309	0.0152	CcSEcCtD
Teniposide—Anorexia—Topotecan—cervical cancer	0.000305	0.0149	CcSEcCtD
Teniposide—ABCG2—endometrium—cervical cancer	0.000304	0.0105	CbGeAlD
Teniposide—TOP2A—lymph node—cervical cancer	0.000295	0.0102	CbGeAlD
Teniposide—NCOA1—HIF-1-alpha transcription factor network—TERT—cervical cancer	0.000294	0.0128	CbGpPWpGaD
Teniposide—ABCG2—mammalian vulva—cervical cancer	0.000294	0.0101	CbGeAlD
Teniposide—CYP3A5—renal system—cervical cancer	0.000291	0.0101	CbGeAlD
Teniposide—Dyspnoea—Topotecan—cervical cancer	0.000285	0.014	CcSEcCtD
Teniposide—TOP2A—Irinotecan—Topotecan—cervical cancer	0.000285	0.121	CbGdCrCtD
Teniposide—ABCG2—uterus—cervical cancer	0.00028	0.00965	CbGeAlD
Teniposide—Decreased appetite—Topotecan—cervical cancer	0.000278	0.0136	CcSEcCtD
Teniposide—CYP2C19—vagina—cervical cancer	0.000268	0.00924	CbGeAlD
Teniposide—Feeling abnormal—Topotecan—cervical cancer	0.000264	0.0129	CcSEcCtD
Teniposide—Gastrointestinal pain—Topotecan—cervical cancer	0.000262	0.0128	CcSEcCtD
Teniposide—TOP2A—Gastric Cancer Network 1—NOTCH1—cervical cancer	0.000259	0.0113	CbGpPWpGaD
Teniposide—Urticaria—Topotecan—cervical cancer	0.000254	0.0125	CcSEcCtD
Teniposide—Abdominal pain—Topotecan—cervical cancer	0.000253	0.0124	CcSEcCtD
Teniposide—Body temperature increased—Topotecan—cervical cancer	0.000253	0.0124	CcSEcCtD
Teniposide—NCOA1—Notch-mediated HES/HEY network—CD4—cervical cancer	0.000248	0.0108	CbGpPWpGaD
Teniposide—ABCG2—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.000237	0.0103	CbGpPWpGaD
Teniposide—Hypersensitivity—Topotecan—cervical cancer	0.000236	0.0116	CcSEcCtD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—CA9—cervical cancer	0.000234	0.0102	CbGpPWpGaD
Teniposide—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—HES1—cervical cancer	0.000233	0.0101	CbGpPWpGaD
Teniposide—CYP2C9—female reproductive system—cervical cancer	0.00023	0.00792	CbGeAlD
Teniposide—Asthenia—Topotecan—cervical cancer	0.00023	0.0112	CcSEcCtD
Teniposide—ABCG2—female gonad—cervical cancer	0.000229	0.00789	CbGeAlD
Teniposide—ABCG2—vagina—cervical cancer	0.000227	0.00784	CbGeAlD
Teniposide—Pruritus—Topotecan—cervical cancer	0.000226	0.0111	CcSEcCtD
Teniposide—Diarrhoea—Topotecan—cervical cancer	0.000219	0.0107	CcSEcCtD
Teniposide—CYP3A4—renal system—cervical cancer	0.000219	0.00754	CbGeAlD
Teniposide—CYP3A5—female gonad—cervical cancer	0.000212	0.00732	CbGeAlD
Teniposide—CYP3A5—vagina—cervical cancer	0.000211	0.00728	CbGeAlD
Teniposide—NCOA1—IL-6 signaling pathway—STAT3—cervical cancer	0.000207	0.00899	CbGpPWpGaD
Teniposide—Vomiting—Topotecan—cervical cancer	0.000203	0.00997	CcSEcCtD
Teniposide—Rash—Topotecan—cervical cancer	0.000202	0.00989	CcSEcCtD
Teniposide—Dermatitis—Topotecan—cervical cancer	0.000202	0.00988	CcSEcCtD
Teniposide—Headache—Topotecan—cervical cancer	0.0002	0.00982	CcSEcCtD
Teniposide—NCOA1—Notch-mediated HES/HEY network—STAT3—cervical cancer	0.000192	0.00837	CbGpPWpGaD
Teniposide—Nausea—Topotecan—cervical cancer	0.00019	0.00931	CcSEcCtD
Teniposide—NCOA1—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.000178	0.00774	CbGpPWpGaD
Teniposide—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—cervical cancer	0.000176	0.00766	CbGpPWpGaD
Teniposide—CYP3A4—female reproductive system—cervical cancer	0.000175	0.00604	CbGeAlD
Teniposide—NCOA1—Leptin signaling pathway—MTOR—cervical cancer	0.000171	0.00745	CbGpPWpGaD
Teniposide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000171	0.00745	CbGpPWpGaD
Teniposide—ABCG2—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.000166	0.00721	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—UBE3A—cervical cancer	0.000165	0.00717	CbGpPWpGaD
Teniposide—TOP2A—Gastric Cancer Network 2—CTNNB1—cervical cancer	0.000163	0.0071	CbGpPWpGaD
Teniposide—NCOA3—Androgen receptor signaling pathway—CTNNB1—cervical cancer	0.00016	0.00696	CbGpPWpGaD
Teniposide—ABCG2—lymph node—cervical cancer	0.000147	0.00507	CbGeAlD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—CASP8—cervical cancer	0.000144	0.00626	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.00014	0.00609	CbGpPWpGaD
Teniposide—NCOA3—Androgen receptor signaling pathway—STAT3—cervical cancer	0.00014	0.00607	CbGpPWpGaD
Teniposide—NCOA1—Androgen receptor signaling pathway—CTNNB1—cervical cancer	0.000132	0.00576	CbGpPWpGaD
Teniposide—NCOA1—Leptin signaling pathway—STAT3—cervical cancer	0.000132	0.00576	CbGpPWpGaD
Teniposide—NCOA1—Generic Transcription Pathway—RARB—cervical cancer	0.000131	0.0057	CbGpPWpGaD
Teniposide—TOP2A—Gastric Cancer Network 2—EGFR—cervical cancer	0.000129	0.00562	CbGpPWpGaD
Teniposide—NCOA3—Androgen receptor signaling pathway—EGFR—cervical cancer	0.000127	0.00552	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—MTOR—cervical cancer	0.000118	0.00515	CbGpPWpGaD
Teniposide—NCOA1—Androgen receptor signaling pathway—STAT3—cervical cancer	0.000115	0.00502	CbGpPWpGaD
Teniposide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000113	0.00491	CbGpPWpGaD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—MTOR—cervical cancer	0.000112	0.00487	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—CASP3—cervical cancer	0.000109	0.00473	CbGpPWpGaD
Teniposide—CYP3A4—Tryptophan metabolism—UBE3A—cervical cancer	0.000109	0.00473	CbGpPWpGaD
Teniposide—TOP2A—Gastric Cancer Network 2—TP53—cervical cancer	0.000109	0.00472	CbGpPWpGaD
Teniposide—NCOA1—Androgen receptor signaling pathway—EGFR—cervical cancer	0.000105	0.00456	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	0.000105	0.00456	CbGpPWpGaD
Teniposide—NCOA1—Adipogenesis—CTNNB1—cervical cancer	9.78e-05	0.00425	CbGpPWpGaD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—TERT—cervical cancer	9.49e-05	0.00413	CbGpPWpGaD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—TP53—cervical cancer	9.4e-05	0.00409	CbGpPWpGaD
Teniposide—NCOA1—Generic Transcription Pathway—NOTCH2—cervical cancer	8.68e-05	0.00378	CbGpPWpGaD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—STAT3—cervical cancer	8.64e-05	0.00376	CbGpPWpGaD
Teniposide—NCOA1—Adipogenesis—STAT3—cervical cancer	8.52e-05	0.00371	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—EGFR—cervical cancer	8.31e-05	0.00361	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—HES1—cervical cancer	8.1e-05	0.00352	CbGpPWpGaD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—EGFR—cervical cancer	7.85e-05	0.00342	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—CA9—cervical cancer	6.98e-05	0.00304	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—TP53—cervical cancer	6.98e-05	0.00304	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—HES1—cervical cancer	6.7e-05	0.00292	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—RARB—cervical cancer	6.31e-05	0.00275	CbGpPWpGaD
Teniposide—ABCG2—Fluoropyrimidine Activity—TP53—cervical cancer	6.29e-05	0.00274	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—NOTCH1—cervical cancer	6.12e-05	0.00266	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—CA9—cervical cancer	5.77e-05	0.00251	CbGpPWpGaD
Teniposide—NCOA1—Generic Transcription Pathway—NOTCH1—cervical cancer	5.37e-05	0.00234	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	5.22e-05	0.00227	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—NOTCH1—cervical cancer	5.06e-05	0.0022	CbGpPWpGaD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—TP53—cervical cancer	4.75e-05	0.00207	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—NOTCH2—cervical cancer	4.18e-05	0.00182	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—CTNNB1—cervical cancer	4.06e-05	0.00177	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	3.95e-05	0.00172	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	3.81e-05	0.00166	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—STAT3—cervical cancer	3.54e-05	0.00154	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—CTNNB1—cervical cancer	3.36e-05	0.00146	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—EGFR—cervical cancer	3.22e-05	0.0014	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	3.02e-05	0.00131	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—STAT3—cervical cancer	2.93e-05	0.00127	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—TERT—cervical cancer	2.88e-05	0.00125	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—MTHFR—cervical cancer	2.83e-05	0.00123	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—EGFR—cervical cancer	2.66e-05	0.00116	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—NOTCH1—cervical cancer	2.59e-05	0.00113	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	2.53e-05	0.0011	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—TP53—cervical cancer	2.43e-05	0.00106	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—MTHFR—cervical cancer	2.34e-05	0.00102	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—CA9—cervical cancer	1.86e-05	0.000811	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—CA9—cervical cancer	1.33e-05	0.000581	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—TP53—cervical cancer	1.1e-05	0.000477	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—CA9—cervical cancer	1.03e-05	0.000449	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—CA9—cervical cancer	9.41e-06	0.000409	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—MTHFR—cervical cancer	7.56e-06	0.000329	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—CA9—cervical cancer	6.21e-06	0.00027	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—MTHFR—cervical cancer	5.42e-06	0.000236	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—MTHFR—cervical cancer	4.19e-06	0.000182	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—MTHFR—cervical cancer	3.82e-06	0.000166	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—MTHFR—cervical cancer	2.52e-06	0.00011	CbGpPWpGaD
